SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease

This study has been completed.

Study NCT00361959 Information provided by GlaxoSmithKline

First Received: August 7, 2006 No Changes Posted

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiration Disorders

More general conditions related to this trial

Respiratory Tract Diseases

Interventions listed in this trial

Tiotropium bromide 18mcg

Additional drug interventions recognized in this trial

Bromides
Fluticasone
Salmeterol
Tiotropium

Sponsors listed in this trial

GlaxoSmithKline

Back to top of Main Content